Literature DB >> 9125540

Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis.

K B Seydel1, E Li, P E Swanson, S L Stanley.   

Abstract

The protozoan parasite Entamoeba histolytica causes amebic dysentery and amebic liver abscess, diseases associated with significant morbidity and mortality worldwide. E. histolytica infection appears to involve the initial attachment of amebic trophozoites to intestinal epithelial cells, followed by lysis of these cells and subsequent invasion into the submucosa. A recent in vitro study (L. Eckmann, S. L. Reed, J. R. Smith, and M. F. Kagnoff, J. Clin. Invest. 96:1269-1279, 1995) demonstrated that incubation of E. histolytica trophozoites with epithelial cell lines results in epithelial cell production of inflammatory cytokines, including interleukin-1 (IL-1) and IL-8, suggesting that intestinal epithelial cell production of cytokines might play a role in the inflammatory response and tissue damage seen in intestinal amebiasis. To determine whether intestinal epithelial cell production of IL-1 and IL-8 occurs in response to E. histolytica infection in vivo and as an approach to studying the specific interactions between amebic trophozoites and human intestine, we used a SCID mouse-human intestinal xenograft (SCID-HU-INT) model of disease, where human intestinal xenografts were infected with virulent E. histolytica trophozoites. Infection of xenografts with E. histolytica trophozoites resulted in extensive tissue damage, which was associated with the development of an early inflammatory response composed primarily of neutrophils. Using oligonucleotide primers that specifically amplify human IL-1beta and IL-8, we could demonstrate by reverse transcription PCR that mRNA for both IL-1beta and IL-8 is produced by human intestinal xenografts in response to amebic infection. The increase in human intestinal IL-1beta and IL-8 in response to invasive amebiasis was confirmed by enzyme-linked immunosorbent assays specific for human IL-1beta and IL-8. Using immunohistochemistry, we confirmed that human intestinal epithelial cells were the source of IL-8 in infected xenografts and established that IL-8 production can occur at sites distal to areas of intestinal mucosal damage. These results demonstrate that human intestinal epithelial cells can produce inflammatory cytokines in response to infection in vivo and establish the SCID-HU-INT model as a system for studying the interactions between E. histolytica and human intestine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125540      PMCID: PMC175187          DOI: 10.1128/iai.65.5.1631-1639.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Fatal amebiasis: report of 148 fatal cases from the Armed Forces Institutes of Pathology.

Authors:  B H KEAN; H R GILMORE; W W VAN STONE
Journal:  Ann Intern Med       Date:  1956-05       Impact factor: 25.391

2.  Pathology of human amebiasis.

Authors:  H Brandt; R P Tamayo
Journal:  Hum Pathol       Date:  1970-09       Impact factor: 3.466

3.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

4.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules.

Authors:  H C Yan; I Juhasz; J Pilewski; G F Murphy; M Herlyn; S M Albelda
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Interaction between trophozoites of Entamoeba histolytica and the human intestinal cell line HT-29 in the presence or absence of leukocytes.

Authors:  G D Burchard; G Prange; D Mirelman
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

7.  [Interleukin-8 gene expression in the human colon epithelial cell line, HT-29, exposed to Entamoeba histolytica].

Authors:  J M Kim; H C Jung; K Im; Y J Cho; C Y Kim
Journal:  Korean J Parasitol       Date:  1995-12       Impact factor: 1.341

8.  Interleukin 8: cells of origin in inflammatory bowel disease.

Authors:  M C Grimm; S K Elsbury; P Pavli; W F Doe
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.

Authors:  Y R Mahida; M Ceska; F Effenberger; L Kurlak; I Lindley; C J Hawkey
Journal:  Clin Sci (Lond)       Date:  1992-03       Impact factor: 6.124

10.  Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

Authors:  S K Dower; S R Kronheim; C J March; P J Conlon; T P Hopp; S Gillis; D L Urdal
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  45 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; James P Nataro; Beth A McCormick; Karen A Krogfelt
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

3.  Cytokine expression in CD4(+) cells exposed to the monocyte locomotion inhibitory factor produced by Entamoeba histolytica.

Authors:  Sara Rojas-Dotor; Guadalupe Rico; Julia Pérez; Juan Velázquez; Raúl Silva; Esther Morales; Roberto Kretschmer
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

Review 4.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

5.  Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease.

Authors:  Hannelore Lotter; Thomas Jacobs; Iris Gaworski; Egbert Tannich
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 6.  Epithelial cells as sensors for microbial infection.

Authors:  M F Kagnoff; L Eckmann
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.

Authors:  Zhi Zhang; Michael Duchêne; Samuel L Stanley
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease.

Authors:  Zhi Zhang; Sajan Mahajan; Xiaochung Zhang; Samuel L Stanley
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Human amebiasis: breaking the paradigm?

Authors:  Cecilia Ximénez; Rene Cerritos; Liliana Rojas; Silvio Dolabella; Patricia Morán; Mineko Shibayama; Enrique González; Alicia Valadez; Eric Hernández; Olivia Valenzuela; Angélica Limón; Oswaldo Partida; Edwards F Silva
Journal:  Int J Environ Res Public Health       Date:  2010-03-16       Impact factor: 3.390

10.  An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis.

Authors:  Devendra Bansal; Patrick Ave; Sophie Kerneis; Pascal Frileux; Olivier Boché; Anne Catherine Baglin; Geneviève Dubost; Anne-Sophie Leguern; Marie-Christine Prevost; Rivka Bracha; David Mirelman; Nancy Guillén; Elisabeth Labruyère
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.